ӳ����ý

A large genetic study of venous thromboembolism could lead to better ways of identifying and treating people at high risk for the disease.

New partnership will expand power of polygenic risk scores to help clinicians predict and prevent disease

Tests based on millions of common DNA variants reveal hidden disease risk; researchers work to bring them to the clinic

Through “polygenic risk scoring,” researchers can identify people at high risk for disease, even if they don’t present other warning signs; method shows potential for use in the clinic